Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Improving Equality, Diversity and Inclusiveness.

The University of Oxford is committed to fostering an inclusive culture which promotes equality, values diversity and maintains a working, learning and social environment in which the rights and dignity of all its staff and students are respected. We recognise that a diverse staff and student body strengthens our research and enhances our teaching due to their broad range of life experiences, and that in order for Oxford to remain a world-leading institution we must continue to provide a diverse, inclusive, fair and open environment that allows everyone to grow and flourish.

The Oxford Neuroscience Community has been developing a unified strategy to achieve positive change in academic diversity. We are working on a number of initiatives that aim to improve equality of opportunity and inclusion in our workplaces, including development and adoption of evidence-based best practices.

ALBA is a network of brain scientists committed to fostering fair & diverse scientific communities. They have drafted the ALBA declaration as a resource for concrete, positive, evidence-based actions that individuals and organizations at any level can take to promote equity & inclusivity. ALBA believe that adopting the actions in the declaration will benefit all members of the research community and the scientific enterprise itself.

Oxford Neuroscience is proud to be a signatory of the ALBA Declaration.

Similar stories

New WA Handley Chair of Psychiatry Appointed

Strategic Developments

Professor John Geddes has been appointed to the WA Handley Professorship of Psychiatry and will take up this post in November 2021.

Investigating New Treatment for Schizophrenia

Research Highlights Strategic Developments

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim has been announced to investigate a new drug target for the treatment of schizophrenia.

Retirement of Professor Peter Brown

Strategic Developments

This month sees the retirement of Professor Peter Brown as Director of the Medical Research Council Brain Network Dynamics Unit at the University of Oxford.

Recognition of Distinction Awards 2020

Awards and Honours Strategic Developments

It is a great pleasure to announce that a number of Neuroscience researchers have been successful in the recent assessment process for the conferment of the title of full Professor.

Ambitious Oxford initiative launched to address graduate under-representation

Strategic Developments

Oxford University and its colleges have announced a major new scholarship scheme for black graduate students as part of a programme to transform its graduate population by creating more funding opportunities for under-represented groups.

Einstein Visiting Fellowship awarded to Zoltán Molnár

Awards and Honours Strategic Developments

Professor Zoltán Molnár has been awarded an Einstein Visiting Fellowship to Charité - University Medicine, Berlin. This award sees him join the dynamic Oxford | Berlin collaboration, a strategic research partnership that supports high quality joint research initiatives across all disciplines of its member institutions, of which Neuroscience is a major focus.